Neurona Therapeutics

📍 South San Francisco, United States👥 112 employees💰 Last funded Mar 2025
Biotechnology Research🌐 neuronatherapeutics.com
Website LinkedIn
Neurona is a biotherapeutics company developing neural cell therapies with single-dose curative potential for the treatment of chronic neurological disorders. Based on a novel neural cell lineage pioneered by the company’s scientific founders, Neurona has built a robust regenerative platform and is developing neuronal, glial, and gene-edited cell therapy candidates that provide long-term repair of dysfunctional neural networks for multiple neurological disorders. For more information about Neurona visit our website.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Neurona Therapeutics?
Neurona Therapeutics has 1 investors on record on gritt.io.
When did Neurona Therapeutics last raise funding?
The most recent investment in Neurona Therapeutics recorded on gritt.io was in March 2025.
What industry is Neurona Therapeutics in?
Neurona Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Neurona Therapeutics based?
Neurona Therapeutics is headquartered in South San Francisco, United States.